Nvidia Invests $50M into AI Drug Discovery Firm Recursion

Artificial Intelligence: AI News, ChatGPT, OpenAI, LLM, Anthropic, Claude, Google AI by Jaeden Schafer

Episode notes

Dive into the future of pharmaceutical innovation as Nvidia commits a significant $50 million investment into Recursion, a pioneering AI drug discovery firm. Explore the potential breakthroughs and advancements at the intersection of artificial intelligence and life-saving medicines.


Get on the AI Box Waitlist: https://AIBox.ai/
Join our ChatGPT Community: https://www.facebook.com/groups/739308654562189/
Follow me on Twitter: https://twitter.com/jaeden_ai